Interventional Cardiology Global Market - Forecast to 2023

Publishing Date : March, 2017
Report Code : HCMD 0117
Price:
Single license $4,950
Site license $6,750
Global license $9,000


Interventional cardiology specifically deals with the catheter based treatment of cardiovascular and structural heart diseases. Products of interventional cardiology market are Catheters, Interventional Diagnostic Catheters, stents, valves, transcatheter heart pump and others. Catheters are segmented into Guide Catheter, Balloon Catheter, Atherectomy Catheters, Thrombectomy Catheters, and Ablation Catheters. Interventional Diagnostic Catheters are segmented into Intravascular ultrasound (IVUS), Fractional flow reserve (FFR), Optical coherence tomography (OCT), Angiograph, Pulmonary artery catheter, Electrophysiology catheter. Stents are further categorised into bare metal stents, drug eluting stents, Bioresorbable stents and Stent grafts. Valves are further divided into Transcatheter Aortic Valve, Annuloplasty Ring, Mitral Clip, and Valvuloplasty. Others are segmented into closure devices (Occluders), Inferior vena cava filters, Guide wires, Transcatheter pacemaker, and accessories.

Applications of Interventional cardiology market are segmented into Diagnostic catheterization, Coronary Interventions, Peripheral interventions and Structural Heart. Coronary intervention application is sub-segmented into Aortic aneurysm (EAVR, TEVAR), Coronary Thrombectomy, PCTA, Coronary Cardiac Ablation and others. Peripheral interventions are sub-segmented into Peripheral Aneurysm, Peripheral Thrombectomy, Peripheral Angioplasty, Peripheral Ablation, Pulmonary embolism, and others. Structural heart is further sub-segmented into Valve replacement, Valve repair, Heart Assist Device, Congenital heart defect and others.

The interventional cardiology global market is expected to grow at a CAGR of high single digit CAGR to reach $46,124.1 million by 2023. Among the Interventional cardiology products, the stents market dominated the products market by occupying a largest share. At the same time, Transcatheter heart pump market is the fastest growing segment projected to grow at a high double digit CAGR. In applications, Coronary Interventions is the largest segment and Structural Heart is the fastest growing segment with the strong CAGR.

Geographical wise, North America is the largest market followed by Europe and Asia-Pacific. The APAC region is projected to be the fastest growing region suggesting an opportunities for growth and likely to get attention of new investors in the interventional cardiology market. Growth in the Asian market is attributed to rising prevalence of lifestyle diseases, ageing population and government initiatives in establishing innovative technologies.

Increasing incidences of cardiovascular diseases due to change in lifestyle, Demand for minimally invasive treatment due to less complication, Rise in the number of Cardiovascular disorders and ageing population, awareness of minimally invasive procedures and newly invented devices, raise in number of clinical studies performed are some of the drivers in the Interventional cardiology global market. Many entry level barriers, stringent regulation and lack of skilled and trained professionals are some of the factors hampering the growth of Interventional cardiology market.

The interventional cardiology global market is a consolidated, highly competitive market and all the existing players in this market are involved in developing new and advanced products to maintain their market shares. Some of the key players of the interventional cardiology market are Abbott Laboratories (U.S.), Boston Scientific (U.S.), B. Braun Melsungen AG (Germany), C.R. Bard, Inc. (U.S.), Edwards Lifesciences (U.S.), Medtronic PLC (Ireland), Terumo Corporation (Japan), Johnson & Johnson (U.S.).

  • 1     EXECUTIVE SUMMARY
  • 2     INTRODUCTION
    • 2.1     KEY TAKEAWAYS
    • 2.2     REPORT DESCRIPTION
    • 2.3     MARKETS COVERED
    • 2.4     STAKEHOLDERS
    • 2.5     RESEARCH METHODOLOGY
      • 2.5.1     MARKET SIZE ESTIMATION
      • 2.5.2     MARKET BREAKDOWN AND DATA TRIANGULATION
      • 2.5.3     SECONDARY SOURCES
      • 2.5.4     PRIMARY SOURCES
      • 2.5.5     KEY DATA POINTS FROM SECONDARY SOURCES
      • 2.5.6     KEY DATA POINTS FROM PRIMARY SOURCES
      • 2.5.7     ASSUMPTIONS
  • 3     MARKET ANALYSIS
    • 3.1     INTRODUCTION
    • 3.2     MARKET SEGMENTATION
    • 3.3     FACTORS INFLUENCING MARKET
      • 3.3.1     DRIVERS AND OPPORTUNITIES
        • 3.3.1.1     INCREASE IN PREVALENCE OF CARDIOVASCULAR DISORDERS DUE TO RISE IN AGING POPULATION
        • 3.3.1.2     INCREASING NUMBER OF INTERVENTIONAL PROCEDURES
        • 3.3.1.3     RISE IN THE NUMBER OF CLINICAL STUDIES PERFORMED
        • 3.3.1.4     INCREASING PREVALENCE OF LIFESTYLE DISEASES
        • 3.3.1.5     TECHNOLOGY ADVANCEMENTS AND GROWING HEALTHCARE BUDGETARY ALLOCATION
        • 3.3.1.6     GROWTH IN EMERGING COUNTRIES
        • 3.3.1.7     INCREASE IN PATIENT AWARENESS FOR MINIMAL INVASIVE SURGERIES
      • 3.3.2     RESTRAINTS AND THREATS
        • 3.3.2.1     STRINGENT REGULATORY REQUIREMENTS WITH HIGH COST OF DEVELOPMENT
        • 3.3.2.2     LACK OF SKILLED AND TRAINED PROFESSIONALS
        • 3.3.2.3     AVAILABILITY OF ALTERNATIVES PRODUCTS AND PROCEDURES
        • 3.3.2.4     REIMBURSEMENT ISSUES IN EMERGING COUNTRIES
    • 3.4     REGULATORY AFFAIRS
      • 3.4.1     INTERNATIONAL ORGANIZATION FOR STANDARDIZATION
      • 3.4.2     U.S.
      • 3.4.3     CANADA
      • 3.4.4     EUROPE
      • 3.4.5     CHINA
      • 3.4.6     JAPAN
      • 3.4.7     INDIA
    • 3.5     REIMBURSEMENT SCENARIO
      • 3.5.1     REIMBURSEMENT TABLE
        • 3.5.1.1     DIAGNOSTIC CARDIAC CATHETERIZATION
        • 3.5.1.2     CORONARY ANGIOPLASTY (PTCA), WITHOUT STENT
        • 3.5.1.3     CORONARY ATHERECTOMY (PTCA), WITHOUT STENT
        • 3.5.1.4     NON-DRUG-ELUTING STENT WITH ANGIOPLASTY (PTCA)
        • 3.5.1.5     DRUG-ELUTING STENT WITH ANGIOPLASTY (PTCA)
        • 3.5.1.6     NON DRUG-ELUTING STENT WITH ATHERECTOMY
        • 3.5.1.7     DRUG-ELUTING STENT WITH ATHERECTOMY
        • 3.5.1.8     NON-DRUG-ELUTING STENT CORONARY REVASCULARIZATION
        • 3.5.1.9     ACUTE MYOCARDIAL INFARCTION
        • 3.5.1.10     CHRONIC TOTAL OCCLUSION
        • 3.5.1.11     DRUG-ELUTING STENT CORONARY REVASCULARIZATION
        • 3.5.1.12     ACUTE MYOCARDIAL INFARCTION
        • 3.5.1.13     CHRONIC TOTAL OCCLUSION
        • 3.5.1.14     INTRAVASCULAR ULTRASOUND
        • 3.5.1.15     FRACTIONAL FLOW RESERVE
        • 3.5.1.16     INTRAVASCULAR ULTRASOUND (PERIPHERAL INTERVENTIONS)
        • 3.5.1.17     PERCUTANEOUS BALLOON VALVULOPLASTY; AORTIC VALVE
        • 3.5.1.18     ENDOVASCULAR OR TRANSTHORACIC VALVES
        • 3.5.1.19     WATCHMAN TM LEFT ATRIAL APPENDAGE CLOSURE (LAAC) PROCEDURE
        • 3.5.1.20     THROMBECTOMY
        • 3.5.1.21     ANEURYSM
    • 3.6     CLINICL TRIAL DATA
    • 3.7     PATENT TRENDS
    • 3.8     TECHNOLOGICAL ADVANCEMENTS
      • 3.8.1     INTRODUCTION
      • 3.8.2     CARDIAC OR VENTRICULAR REMODELLING AND HEART PUMP
      • 3.8.3     TRANSCATHETER MITRAL VALVE REPLACEMENT (TMVR)
    • 3.9     PORTER’S FIVE FORCE ANALYSIS
      • 3.9.1     THREAT OF NEW ENTRANTS
      • 3.9.2     THREAT OF SUBSTITUTES
      • 3.9.3     BARGAINING POWER OF SUPPLIERS
      • 3.9.4     BARGAINING POWER OF BUYERS
      • 3.9.5     COMPETITIVE RIVALRY
    • 3.10     PEDIATRIC INTERVENTIONAL CARDIOLOGY
    • 3.11     SUPPLY CHAIN ANALYSIS
    • 3.12     MARKET SHARE ANALYSIS BY MAJOR PLAYERS
  • 4     INTERVENTIONAL CARDIOLOGY GLOBAL MARKET, BY PRODUCT
    • 4.1     INTRODUCTION
    • 4.2     CATHETERS
      • 4.2.1     GUIDE CATHETER
      • 4.2.2     BALLOON CATHETERS
      • 4.2.3     ATHERECTOMY CATHETERS
        • 4.2.3.1     DIRECTIONAL ATHERECTOMY CATHETER
        • 4.2.3.2     ROTATIONAL ATHERECTOMY CATHETER
        • 4.2.3.3     ORBITAL ATHERECTOMY CATHETER
        • 4.2.3.4     LASER ATHERECTOMY CATHETER
      • 4.2.4     THROMBECTOMY CATHETERS
      • 4.2.5     ABLATION CATHETERS
        • 4.2.5.1     RADIOFREQUENCY ABLATION
        • 4.2.5.2     OTHERS
    • 4.3     INTERVENTIOAL DIAGNOSTIC CATHETERS
      • 4.3.1     INTRAVASCULAR ULTRASOUND (IVUS) CATHETER
      • 4.3.2     FRACTIONAL FLOW RESERVE (FFR) CATHETER
      • 4.3.3     OPTICAL COHERENCE TOMOGRAPHY (OCT) CATHETER
      • 4.3.4     ANGIOGRAPHIC CATHETER
      • 4.3.5     PULMONARY ARTERY CATHETER (PAC)
      • 4.3.6     ELECTROPHYSIOLOGY CATHETER
    • 4.4     STENTS
      • 4.4.1     BARE METAL STENTS
      • 4.4.2     DRUG ELUTING STENTS
      • 4.4.3     BIORESORBABLE STENTS
      • 4.4.4     STENT GRAFTS
    • 4.5     VALVES
      • 4.5.1     TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR)
      • 4.5.2     ANNULOPLASTY RING
      • 4.5.3     MITRAL CLIP
      • 4.5.4     VALVULOPLASTY
    • 4.6     TRANSCATHETER HEART PUMP
    • 4.7     OTHERS
      • 4.7.1     OCCLUDERS
      • 4.7.2     INFERIOR VENA CAVA FILTERS
      • 4.7.3     OTHERS
  • 5     INTERVENTIONAL CARDIOLOGY GLOBAL MARKET, BY APPLICATION
    • 5.1     INTRODUCTION
    • 5.2     DIAGNOSTIC CATHETERIZATION
    • 5.3     CORONARY INTERVENTIONS
      • 5.3.1     AORTIC ANEURYSM
      • 5.3.2     CORONARY THROMBECTOMY
      • 5.3.3     PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA)
      • 5.3.4     CORONARY ABLATION
      • 5.3.5     OTHER CORONARY INTERVENTIONS
    • 5.4     PERIPHERAL INTERVENTIONS
      • 5.4.1     PERIPHERAL ANEURYSM
      • 5.4.2     PERIPHERAL THROMBECTOMY
      • 5.4.3     PERIPHERAL ANGIOPLASTY
      • 5.4.4     PERIPHERAL ABLATION
      • 5.4.5     PULMONARY EMBOLISM
      • 5.4.6     OTHER PERIPHERAL INTERVENTIONS
    • 5.5     STRUCTURAL HEART
      • 5.5.1     VALVE REPLACEMENT
      • 5.5.2     VALVE REPAIR (MITRAL CLIP)
      • 5.5.3     HEART ASSIST DEVICE
      • 5.5.4     CONGENITAL HEART DEFECT
      • 5.5.5     OTHERS
  • 6     REGIONAL ANALYSIS
    • 6.1     INTRODUCTION
    • 6.2     NORTH AMERICA
      • 6.2.1     U.S.
      • 6.2.2     OTHERS
    • 6.3     EUROPE
      • 6.3.1     GERMANY
      • 6.3.2     FRANCE
      • 6.3.3     U.K.
      • 6.3.4     OTHERS
    • 6.4     APAC
      • 6.4.1     JAPAN
      • 6.4.2     CHINA
      • 6.4.3     INDIA
      • 6.4.4     OTHERS
    • 6.5     ROW
      • 6.5.1     BRAZIL
      • 6.5.2     MIDDLE EAST
      • 6.5.3     OTHERS
  • 7     COMPANY DEVELOPMENTS
    • 7.1     INTRODUCTION
    • 7.2     APPROVALS
    • 7.3     ACQUISITIONS AND MERGERS
    • 7.4     NEW PRODUCT LAUNCH
    • 7.5     AGREEMENTS, PARTNERSHIPS, COLLABORATIONS AND JOINT VENTURES
    • 7.6     OTHER DEVELOPMENTS
  • 8     MAJOR COMPANIES
    • 8.1     ABBOTT LABORATORIES
      • 8.1.1     OVERVIEW
      • 8.1.2     FINANCIALS
      • 8.1.3     PRODUCT PORTFOLIO
      • 8.1.4     KEY DEVELOPMENTS
      • 8.1.5     BUSINESS STRATEGY
      • 8.1.6     SWOT ANALYSIS
    • 8.2     ABIOMED
      • 8.2.1     OVERVIEW
      • 8.2.2     FINANCIALS
      • 8.2.3     PRODUCT PORTFOLIO
      • 8.2.4     KEY DEVELOPMENTS
      • 8.2.5     BUSINESS STRATEGY
      • 8.2.6     SWOT ANALYSIS
    • 8.3     B.BRAUN MELSUNGEN AG
      • 8.3.1     OVERVIEW
      • 8.3.2     FINANCIALS
      • 8.3.3     PRODUCT PORTFOLIO
      • 8.3.4     KEY DEVELOPMENTS
      • 8.3.5     BUSINESS STRATEGY
      • 8.3.6     SWOT ANALYSIS
    • 8.4     BOSTON SCIENTIFIC CORPOARTION
      • 8.4.1     OVERVIEW
      • 8.4.2     FINANCIALS
      • 8.4.3     PRODUCT PORTFOLIO
      • 8.4.4     KEY DEVELOPMENTS
      • 8.4.5     BUSINESS STRATEGY
      • 8.4.6     SWOT ANALYSIS
    • 8.5     C.R.BARD INC.
      • 8.5.1     OVERVIEW
      • 8.5.2     FINANCIALS
      • 8.5.3     PRODUCT PORTFOLIO
      • 8.5.4     KEY DEVELOPMENTS
      • 8.5.5     BUSINESS STRATEGY
      • 8.5.6     SWOT ANALYSIS
    • 8.6     COOK MEDICAL, INC.
      • 8.6.1     OVERVIEW
      • 8.6.2     FINANCIALS
      • 8.6.3     PRODUCT PORTFOLIO
      • 8.6.4     KEY DEVELOPMENTS
      • 8.6.5     BUSINESS STRATEGY
      • 8.6.6     SWOT ANALYSIS
    • 8.7     EDWARDS LIFESCIENCES CORP.
      • 8.7.1     OVERVIEW
      • 8.7.2     FINANCIALS
      • 8.7.3     PRODUCT PORTFOLIO
      • 8.7.4     KEY DEVELOPMENTS
      • 8.7.5     BUSINESS STRATEGY
      • 8.7.6     SWOT ANALYSIS
    • 8.8     JOHNSON & JOHNSON (BIOSENSE WEBSTER)
      • 8.8.1     OVERVIEW
      • 8.8.2     FINANCIALS
      • 8.8.3     PRODUCT PORTFOLIO
      • 8.8.4     KEY DEVELOPMENTS
      • 8.8.5     BUSINESS STRATEGY
      • 8.8.6     SWOT ANALYSIS
    • 8.9     MEDTRONIC PLC
      • 8.9.1     OVERVIEW
      • 8.9.2     FINANCIALS
      • 8.9.3     PRODUCT PORTFOLIO
      • 8.9.4     KEY DEVELOPMENTS
      • 8.9.5     BUSINESS STRATEGY
      • 8.9.6     SWOT ANALYSIS
    • 8.10     TERUMO CORPORATION
      • 8.10.1     OVERVIEW
      • 8.10.2     FINANCIALS
      • 8.10.3     PRODUCT PORTFOLIO
      • 8.10.4     KEY DEVELOPMENTS
      • 8.10.5     BUSINESS STRATEGY
      • 8.10.6     SWOT ANALYSIS
    • 8.11     W.L. GORE & ASSOCIATES, INC.
      • 8.11.1     OVERVIEW
      • 8.11.2     FINANCIALS
      • 8.11.3     PRODUCT PORTFOLIO
      • 8.11.4     KEY DEVELOPMENTS
      • 8.11.5     BUSINESS STRATEGY
      • 8.11.6     SWOT ANALYSIS

      LIST OF TABLES

      • TABLE 1     INTERVENTIONAL CARDIOLOGY GLOBAL MARKET REVENUE, BY REGION, (2015 - 2023) ($MN)
      • TABLE 2     INTERVENTIONAL CARDIOLOGY GLOBAL MARKET REVENUE, BY PRODUCTS, (2015-2023) ($MN)
      • TABLE 3     CATHETERS GLOBAL MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 4     CATHETERS GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 5     GUIDE CATHETER GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 6     BALLOON CATHETERS GLOBAL MARKET REVENUE, BY REGION,(2015-2023) ($MN)
      • TABLE 7     ATHERECTOMY CATHETERS GLOBAL MARKET REVENUE, BY REGION,(2015-2023) ($MN)
      • TABLE 8     THROMBECTOMY CATHETERS GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 9     ABLATION CATHETERS GLOBAL MARKET REVENUE,BY REGION, (2015-2023) ($MN)
      • TABLE 10     INTERVENTIONAL DIAGNOSTIC CATHETERS GLOBAL MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 11     INTERVENTIONAL DIAGNOSTIC CATHETERS GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 12     IVUS CATHETER GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 13     FFR GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 14     OCT GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 15     ANGIOGRAPHIC CATHETER GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 16     PULMONARY ARTERY CATHETER GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 17     ELECTROPHYSIOLOGY CATHETER GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 18     STENTS GLOBAL MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 19     STENTS GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 20     BARE METAL STENTS GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 21     DRUG ELUTING STENTS GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 22     BIORESORBABLE STENTS GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 23     STENT GRAFTS GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 24     VALVES GLOBAL MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 25     VALVES GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 26     TRANSCATHETER AORTIC VALVE GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 27     ANNULOPLASTY RING GLOBAL MARKET REVENUE, BY REGION,(2015-2023) ($MN)
      • TABLE 28     MITRAL CLIP GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 29     VALVULOPLASTY GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 30     TRANSCATHETER HEART PUMP GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 31     OTHERS GLOBAL MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 32     OTHERS GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 33     OCCLUDERS GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 34     INFERIOR VENA CAVA FILTERS GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 35     OTHERS GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 36     INTERVENTIONAL CARDIOLOGY GLOBAL MARKET REVENUE, BY APPLICATION, (2015-2023) ($MN)
      • TABLE 37     DIAGNOSTIC CATHETERIZATION GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 38     CORONARY INTERVENTIONS GLOBAL MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 39     CORONARY INTERVENTIONS GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 40     AORTIC ANEURYSM GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 41     CORONARY THROMBECTOMY GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 42     PTCA GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 43     CORONARY ABLATION GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 44     OTHER CORONARY INTERVENTIONS GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 45     PERIPHERAL INTERVENTIONS GLOBAL MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 46     PERIPHERAL INTERVENTIONS GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 47     PERIPHERAL ANEURYSM GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 48     PERIPHERAL THROMBECTOMY GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 49     PERIPHERAL ANGIOPLASTY GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 50     PERIPHERAL ABLATION GLOBAL MARKET REVENUE, BY REGION,(2015-2023) ($MN)
      • TABLE 51     PULMONARY EMBOLISM GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 52     OTHER PERIPHERAL INTERVENTIONS GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 53     STRUCTURAL HEART GLOBAL MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 54     STRUCTURAL HEART GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 55     VALVE REPLACEMENT GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 56     VALVE REPAIR GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 57     HEART ASSIST DEVICE GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 58     CONGENITAL HEART DEFECT GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 59     OTHERS GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 60     INTERVENTIONAL CARDIOLOGY GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 61     NORTH AMERICAN INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY PRODUCT, (2015-2023) ($MN)
      • TABLE 62     NORTH AMERICAN CATHETERS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 63     NORTH AMERICAN INTERVENTIONAL DIAGNOSTIC CATHETERS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 64     NORTH AMERICAN STENTS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 65     NORTH AMERICAN VALVES MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 66     NORTH AMERICAN OTHER PRODUCTS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 67     NORTH AMERICAN INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY APPLICATION, (2015-2023) ($MN)
      • TABLE 68     NORTH AMERICAN CORONARY INTERVENTIONS MARKET REVENUE,BY TYPE, (2015-2023) ($MN)
      • TABLE 69     NORTH AMERICAN PERIPHERAL INTERVENTIONS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 70     NORTH AMERICAN STRUCTURAL HEART MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 71     NORTH AMERICAN INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY COUNTRY, (2015-2023) ($MN)
      • TABLE 72     U.S. INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY PRODUCTS, (2015-2023) ($MN)
      • TABLE 73     U.S INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY APPLICATION, (2015-2023) ($MN)
      • TABLE 74     OTHERS INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY PRODUCT, (2016 V/S 2023) ($MN)
      • TABLE 75     OTHERS INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY APPLICATION, (2015-2023) ($MN)
      • TABLE 76     EUROPE INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY PRODUCT, (2015-2023) ($MN)
      • TABLE 77     EUROPE CATHETERS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 78     EUROPE INTERVENTIONAL DIAGNOSTIC CATHETERS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 79     EUROPE STENTS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 80     EUROPE VALVES MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 81     EUROPE OTHER PRODUCTS MARKET REVENUE, BY TYPE,(2015-2023) ($MN)
      • TABLE 82     EUROPE INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY APPLICATION, (2015-2023) ($MN)
      • TABLE 83     EUROPE CORONARY INTERVENTIONS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 84     EUROPE PERIPHERAL INTERVENTIONS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 85     EUROPE STRUCTURAL HEART MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 86     EUROPE INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY COUNTRY, (2015-2023) ($MN)
      • TABLE 87     GERMANY INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY PRODUCTS, (2015-2023) ($MN)
      • TABLE 88     GERMANY INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY APPLICATION, (2015-2023) ($MN)
      • TABLE 89     FRANCE INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY PRODUCTS, (2015-2023) ($MN)
      • TABLE 90     FRANCE INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY APPLICATION, (2015-2023) ($MN)
      • TABLE 91     U.K. INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY PRODUCTS, (2015-2023) ($MN)
      • TABLE 92     U.K. INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY APPLICATION, (2015-2023) ($MN)
      • TABLE 93     OTHERS INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY PRODUCTS, (2015-2023) ($MN)
      • TABLE 94     OTHERS INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY APPLICATION, (2015-2023) ($MN)
      • TABLE 95     APAC INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY PRODUCT, (2015-2023) ($MN)
      • TABLE 96     APAC CATHETERS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 97     APAC INTERVENTIONAL DIAGNOSTIC CATHETERS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 98     APAC STENTS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 99     APAC VALVES MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 100     APAC OTHER PRODUCTS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 101     APAC INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY APPLICATION, (2015-2023) ($MN)
      • TABLE 102     APAC CORONARY INTERVENTIONS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 103     APAC PERIPHERAL INTERVENTIONS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 104     APAC STRUCTURAL HEART MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 105     APAC INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY COUNTRY, (2015-2023) ($MN)
      • TABLE 106     JAPAN INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY PRODUCTS, (2015-2023) ($MN)
      • TABLE 107     JAPAN INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY APPLICATION, (2015-2023) ($MN)
      • TABLE 108     CHINA INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY PRODUCTS, (2015-2023) ($MN)
      • TABLE 109     CHINA INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY APPLICATION, (2015-2023) ($MN)
      • TABLE 110     INDIA INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY PRODUCTS, (2015-2023) ($MN)
      • TABLE 111     INDIA INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY APPLICATION, (2015-2023) ($MN)
      • TABLE 112     OTHERS INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY PRODUCTS, (2015-2023) ($MN)
      • TABLE 113     OTHERS INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY APPLICATION, (2015-2023) ($MN)
      • TABLE 114     ROW INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY PRODUCT, (2015-2023) ($MN)
      • TABLE 115     ROW CATHETERS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 116     ROW INTERVENTIONAL DIAGNOSTIC CATHETERS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 117     ROW STENTS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 118     ROW VALVES MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 119     ROW OTHER PRODUCTS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 120     ROW INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY APPLICATION, (2015-2023) ($MN)
      • TABLE 121     ROW CORONARY INTERVENTIONS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 122     ROW PERIPHERAL INTERVENTIONS MARKET REVENUE, BY TYPE,(2015-2023) ($MN)
      • TABLE 123     ROW STRUCTURAL HEART MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 124     ROW INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY COUNTRY, (2015-2023) ($MN)
      • TABLE 125     BRAZIL INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY PRODUCTS, (2015-2023) ($MN)
      • TABLE 126     BRAZIL INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY APPLICATION, (2015-2023) ($MN)
      • TABLE 127     MIDDLE EAST INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY PRODUCTS, (2015-2023) ($MN)
      • TABLE 128     MIDDLE EAST INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY APPLICATION, (2015-2023) ($MN)
      • TABLE 129     OTHERS INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY PRODUCTS, (2015-2023) ($MN)
      • TABLE 130     OTHERS INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY APPLICATION, (2015-2023) ($MN)
      • TABLE 131     APPROVALS, (2014-2017)
      • TABLE 132     ACQUISITIONS AND MERGERS, (2014-2017)
      • TABLE 133     NEW PRODUCT LAUNCH, (2014-2017)
      • TABLE 134     AGREEMENTS, PARTNERSHIPS, COLLABORATIONS & JOINT VENTURES, (2014-2017)
      • TABLE 135     OTHER DEVELOPMENTS (2014-2017)
      • TABLE 136     ABBOTT LABORATORIES: TOTAL REVENUE AND R&D EXPENSES,(2014-2016) ($MN)
      • TABLE 137     ABBOTT LABORATORIES: TOTAL REVENUE BY SEGMENTS, (2014-16) ($MN)
      • TABLE 138     ABBOTT LABORATORIES: TOTAL REVENUE BY GEOGRAPHY, (2014-2016) ($MN)
      • TABLE 139     ABIOMED: TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
      • TABLE 140     ABIOMED: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN)
      • TABLE 141     B.BRAUN MELSUNGEN AG: TOTAL REVENUE AND R&D EXPENSES, (2013-2015) ($MN)
      • TABLE 142     B.BRAUN MELSENGEN AG: TOTAL REVENUE, BY SEGMENTS, (2013-2015) ($MN)
      • TABLE 143     B.BRAUN MELSENGEN, AG: TOTAL REVENUE, BY GEOGRAPHY, (2013-2015) ($MN)
      • TABLE 144     BOSTON SCIENTIFIC CORPORATION: TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
      • TABLE 145     BOSTON SCIENTIFIC CORPORATION: TOTAL REVENUE BY SEGMENTS, (2014-2016) ($MN)
      • TABLE 146     BOSTON SCIENTIFIC CORPORATION: CARDIOVASCULAR REVENUE, BY SUB-SEGMNETS, (2014-2016) ($MN)
      • TABLE 147     BOSTON SCIENTIFIC CORPORATION: TOTAL REVENUE BY GEOGRAPHY, (2014-2016) ($MN)
      • TABLE 148     C.R.BARD INC.: TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
      • TABLE 149     C.R.BARD INC: TOTAL REVENUE BY SEGMENTS (2014-16) ($MN)
      • TABLE 150     C.R. BARD: TOTAL REVENUE, BY GEOGRAPHY, (2014-2016) ($MN)
      • TABLE 151     EDWARDS LIFESCIENCES CORP.: TOTAL REVENUE AND R&D EXPENSES (2014-2016) ($MN)
      • TABLE 152     EDWARDS LIFESCIENCES CORP.: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN)
      • TABLE 153     EDWARDS LIFESCIENCES CORP.: TOTAL REVENUE, BY GEOGRAPHY, (2014-2016) ($MN)
      • TABLE 154     JOHNSON & JOHNSON: TOTAL REVENUE AND R&D EXPENSES,(2014-2016) ($MN)
      • TABLE 155     JOHNSON & JOHNSON: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN)
      • TABLE 156     JOHNSON & JOHNSON: TOTAL REVENUE, BY GEOGRAPHY,(2014-2016) ($MN)
      • TABLE 157     MEDTRONIC: TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
      • TABLE 158     MEDTRONIC: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN)
      • TABLE 159     MEDTRONIC: CARDIAC AND VASCULAR GROUP REVENUE, BY SEGMENTS, (2014-2016) ($MN)
      • TABLE 160     MEDTRONIC: TOTAL REVENUE, BY GEOGRAPHY, (2014-2016) ($MN)
      • TABLE 161     TERUMO CORPORATION: TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
      • TABLE 162     TERUMO CORPORATION: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN)
      • TABLE 163     TERUMO CORPORATION: TOTAL REVENUE, BY GEOGRAPHY, (2014-2016) ($MN)

      LIST OF FIGURES

      • FIGURE 1     INTERVENTIONAL CARDIOLOGY GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
      • FIGURE 2     RESEARCH METHODOLOGY: INTERVENTIONAL CARDIOLOGY GLOBAL MARKET
      • FIGURE 3     INTERVENTIONAL CARDIOLOGY GLOBAL MARKET: TOP-DOWN AND BOTTOM-UP APPROACH
      • FIGURE 4     INTERVENTIONAL CARDIOLOGY GLOBAL MARKET: FORECASTING MODEL
      • FIGURE 5     INTERVENTIONAL CARDIOLOGY GLOBAL MARKET: MARKET BREAKDOWN & DATA TRIANGULATION
      • FIGURE 6     INTERVENTIONAL CARDIOLOGY GLOBAL MARKET SEGMENTATION
      • FIGURE 7     MARKET DYNAMICS
      • FIGURE 8     INTERVENTIONAL CARDIOLOGY MARKET: PATENT FILING BY MAJOR PLAYERS (2011-2016)
      • FIGURE 9     INTERVENTIONAL CARDIOLOGY GLOBAL MARKET: PORTER’S ANALYSIS
      • FIGURE 10     INTERVENTIONAL CARDIOLOGY GLOBAL MARKET: SUPPLY CHAIN ANALYSIS
      • FIGURE 11     INTERVENTIONAL CARDIOLOGY GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2016 (%)
      • FIGURE 12     INTERVENTIONAL CARDIOLOGY GLOBAL MARKET REVENUE, BY PRODUCTS (2016) ($MN)
      • FIGURE 13     CATHETERS GLOBAL MARKET REVENUE, BY TYPE (2016 V/S 2023) ($MN)
      • FIGURE 14     CATHETERS GLOBAL MARKET REVENUE, BY REGION, (2016 V/S 2023) (%)
      • FIGURE 15     INTERVENTIONAL DIAGNOSTIC CATHETERS GLOBAL MARKET REVENUE, BY TYPE (2016 V/S 2023) ($MN)
      • FIGURE 16     INTERVENTIONAL DIAGNOSTIC CATHETERS GLOBAL MARKET REVENUE, BY REGION (2016 V/S 2023) (%)
      • FIGURE 17     STENTS GLOBAL MARKET REVENUE, BY TYPE (2016 V/S 2023) ($MN)
      • FIGURE 18     STENTS GLOBAL MARKET REVENUE, BY REGION, (2016 V/S 2023) ($MN)
      • FIGURE 19     BIORESORBABLE STENTS GLOBAL MARKET REVENUE, BY REGION, (2016 V/S 2023) (%)
      • FIGURE 20     VALVES GLOBAL MARKET REVENUE, BY TYPE (2016 V/S 2023) ($MN)
      • FIGURE 21     VALVES GLOBAL MARKET REVENUE, BY REGION, (2016 V/S 2023) (%)
      • FIGURE 22     ANNULOPLASTY RING GLOBAL MARKET REVENUE, BY REGION, (2016 V/S 2023) (%)
      • FIGURE 23     TRANSCATHETER HEART PUMP GLOBAL MARKET REVENUE, BY REGION, (2016 V/S 2023) (%)
      • FIGURE 24     OTHERS GLOBAL MARKET REVENUE, BY TYPE (2016 V/S 2023) ($MN)
      • FIGURE 25     OTHERS MARKET REVENUE, BY REGION, (2016 V/S 2023) (%)
      • FIGURE 26     INTERVENTIONAL CARDIOLOGY GLOBAL MARKET REVENUE,BY APPLICATION, (2016) ($MN)
      • FIGURE 27     CORONARY INTERVENTIONS GLOBAL MARKET REVENUE, BY TYPE, (2016 V/S 2023) ($MN)
      • FIGURE 28     CORONARY INTERVENTIONS GLOBAL MARKET REVENUE, BY REGION, (2016 V/S 2023) (%)
      • FIGURE 29     PERIPHERAL INTERVENTIONS GLOBAL MARKET REVENUE, BY TYPE, (2016 V/S 2023) ($MN)
      • FIGURE 30     PERIPHERAL INTERVENTIONS GLOBAL MARKET REVENUE, BY REGION, (2016 V/S 2023) (%)
      • FIGURE 31     STRUCTURAL HEART GLOBAL MARKET REVENUE, BY TYPE, (2016 V/S 2023) ($MN)
      • FIGURE 32     STRUCTURAL HEART GLOBAL MARKET REVENUE, BY REGION, (2016 V/S 2023) (%)
      • FIGURE 33     HEART ASSIST DEVICE GLOBAL MARKET REVENUE, BY REGION, (2016 V/S 2023) (%)
      • FIGURE 34     INTERVENTIONAL CARDIOLOGY GLOBAL MARKET REVENUE, BY REGION (2015 - 2023) ($MN), CAGR (%)
      • FIGURE 35     NORTH AMERICA INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY PRODUCT, (2016 V/S 2023) ($MN)
      • FIGURE 36     NORTH AMERICA INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY APPLICATION (2016 V/S 2023) ($MN)
      • FIGURE 37     NORTH AMERICA INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY COUNTRY (2016 V/S 2023) (%)
      • FIGURE 38     U.S. INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY PRODUCTS (2016 V/S 2023) ($MN)
      • FIGURE 39     U.S. INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY APPLICATION, (2016 V/S 2023) ($MN)
      • FIGURE 40     OTHERS INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY PRODUCT, (2016 V/S 2023) ($MN)
      • FIGURE 41     OTHERS INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY APPLICATION, (2016 V/S 2023) ($MN)
      • FIGURE 42     EUROPE INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY PRODUCT, (2016 V/S 2023) ($MN)
      • FIGURE 43     EUROPE INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY APPLICATION (2016 V/S 2023) ($MN)
      • FIGURE 44     EUROPE INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY COUNTRY (2016 V/S 2023) (%)
      • FIGURE 45     GERMANY INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY PRODUCTS (2016 V/S 2023) ($MN)
      • FIGURE 46     GERMANY INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY APPLICATION, (2016 V/S 2023) ($MN)
      • FIGURE 47     FRANCE INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY PRODUCTS (2016 V/S 2023) ($MN)
      • FIGURE 48     FRANCE INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY APPLICATION, (2016 V/S 2023) ($MN)
      • FIGURE 49     U.K. INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY PRODUCTS (2016 V/S 2023) ($MN)
      • FIGURE 50     U.K. INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY APPLICATION, (2016 V/S 2023) ($MN)
      • FIGURE 51     OTHERS INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY PRODUCTS (2016 V/S 2023) ($MN)
      • FIGURE 52     OTHERS INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY APPLICATION, (2016 V/S 2023) ($MN)
      • FIGURE 53     APAC INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY PRODUCT, (2016 V/S 2023) ($MN)
      • FIGURE 54     APAC INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY APPLICATION (2016 V/S 2023) ($MN)
      • FIGURE 55     APAC INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY COUNTRY (2016 V/S 2023) (%)
      • FIGURE 56     JAPAN INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY PRODUCTS (2016 V/S 2023) ($MN)
      • FIGURE 57     JAPAN INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY APPLICATION, (2016 V/S 2023) ($MN)
      • FIGURE 58     CHINA INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY PRODUCTS (2016 V/S 2023) ($MN)
      • FIGURE 59     CHINA INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY APPLICATION, (2016 V/S 2023) ($MN)
      • FIGURE 60     INDIA INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY PRODUCTS (2016 V/S 2023) ($MN)
      • FIGURE 61     INDIA INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY APPLICATION, (2016 V/S 2023) ($MN)
      • FIGURE 62     OTHERS INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY PRODUCTS (2016 V/S 2023) ($MN)
      • FIGURE 63     OTHERS INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY APPLICATION, (2016 V/S 2023) ($MN)
      • FIGURE 64     ROW INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY PRODUCT, (2016 V/S 2023) ($MN)
      • FIGURE 65     ROW INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY APPLICATION (2016 V/S 2023) ($MN)
      • FIGURE 66     ROW INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY COUNTRY (2016 V/S 2023) (%)
      • FIGURE 67     BRAZIL INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY PRODUCTS (2016 V/S 2023) ($MN)
      • FIGURE 68     BRAZIL INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY APPLICATION, (2016 V/S 2023) ($MN)
      • FIGURE 69     MIDDLE EAST INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY PRODUCTS (2016 V/S 2023) ($MN)
      • FIGURE 70     MIDDLE EAST INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY APPLICATION, (2016 V/S 2023) ($MN)
      • FIGURE 71     OTHERS INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY PRODUCTS (2016 V/S 2023) ($MN)
      • FIGURE 72     OTHERS INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY APPLICATION, (2016 V/S 2023) ($MN)
      • FIGURE 73     KEY GROWTH STRATEGIES, (2014-2017)
      • FIGURE 74     SWOT: ABBOTT LABORATORIES
      • FIGURE 75     SWOT: ABIOMED
      • FIGURE 76     SWOT: B.BRAUN MELSUNGEN, AG
      • FIGURE 77     SWOT: BOSTON SCIENTIFIC CORPORATION
      • FIGURE 78     SWOT: C.R.BARD, INC.
      • FIGURE 79     SWOT: COOK MEDICAL, INC.
      • FIGURE 80     SWOT: EDWARDS LIFESCIENCES
      • FIGURE 81     SWOT: JOHNSON & JOHNSON
      • FIGURE 82     SWOT: MEDTRONIC
      • FIGURE 83     SWOT: TERUMO CORPORATION
      • FIGURE 84     SWOT: W.L. GORE & ASSOCIATES, INC.

      LIST OF COMPANIES MENTIONED IN THE REPORT

      • 1     ABBOTT LABORATORIES
      • 2     ABIOMED, INC.
      • 3     ACANDIS
      • 4     ACCELLENT INC.
      • 5     ACIST MEDICAL SYSTEMS
      • 6     ADMEDES SCHUESSLER GMBH
      • 7     ALPHA MEDICAL
      • 8     AMG INTERNATIONAL GMBH
      • 9     ANGIODYNAMICS, INC.
      • 10     ANGIOSLIDE, INC.
      • 11     APC CARDIOVASCULAR, LTD.
      • 12     APPLIED MEDICAL
      • 13     ARGON MEDICAL DEVICES
      • 14     ARRAVASC, LTD.
      • 15     ARTICURE INC.
      • 16     ASAHI INTEC
      • 17     ASH ACCESS TECHNOLOGY, INC.
      • 18     ASID BONZ GMBH
      • 19     AVINGER, INC.
      • 20     B. BRAUN MELSUNGEN AG
      • 21     BALTON SP. Z O.O.
      • 22     BAYLIS MEDICAL
      • 23     BIOABSORBABLE THERAPEUTICS, INC.
      • 24     BIOMERICS
      • 25     BIOPHAN TECHNOLOGIES, INC.
      • 26     BIORING SA
      • 27     BIOSENSORS INTERNATIONAL GROUP, LTD.
      • 28     BIOTEQUE CORPORATION
      • 29     BIOTRONIK GMBH & CO.
      • 30     BIOVENTRIX
      • 31     BLUE MEDICAL DEVICES BV
      • 32     BOLTON MEDICAL
      • 33     BOSTON SCIENTIFIC CORPORATION
      • 34     BRAILE BIOMEDICA
      • 35     BROSMED MEDICAL CO.,LTD
      • 36     BURPEE MATERIALS TECHNOLOGY, L.L.C.
      • 37     C. R. BARD, INC.
      • 38     CAPPELLA INC.
      • 39     CAPTURE VASCULAR SYSTEM
      • 40     CARDIATIS
      • 41     CARDIO MED
      • 42     CARDIOFOCUS, INC.
      • 43     CARDIONOVUM GMBH
      • 44     CARDIOVASCULAR SYSTEMS, INC.
      • 45     CARDIVA MEDICAL, INC.
      • 46     CATHRX LTD.
      • 47     CID SRL
      • 48     CLARET MEDICAL, INC.
      • 49     CLEARSTREAM TECHNOLOGIES GROUP PLC
      • 50     CONCENTRIC MEDICAL
      • 51     CONTROL MEDICAL TECHNOLOGY
      • 52     COOK MEDICAL
      • 53     CORNOVA, INC.
      • 54     CRADINAL HEALTH
      • 55     DEVAX, INC.
      • 56     DIROS TECHNOLOGY
      • 57     DISA VASCULAR (PTY) LTD.
      • 58     DISPOMEDICA GMBH
      • 59     EDWARDS LIFESCIENCES
      • 60     ELIXIR MEDICAL CORPORATION
      • 61     ENDOCOR GMBH
      • 62     ENDOLOGIX INCORPORATED
      • 63     ENDOSPAN
      • 64     EUCATECH AG
      • 65     EUROCOR GMBH
      • 66     FCARE SYSTEMS
      • 67     FORTIMEDIX B.V
      • 68     FUJI SYSTEMS CORPORATION
      • 69     GETINGE GROUP
      • 70     GOODMAN CO., LTD.
      • 71     HANSEN MEDICAL
      • 72     HEARTFLOW
      • 73     HEXACATH
      • 74     IBERHOSPITEX S.A
      • 75     ICON MEDICAL CORP.
      • 76     ICU MEDICALS
      • 77     INFRAREDX, INC.
      • 78     INSITU TECHNOLOGIES INC.
      • 79     INSPIREMED LTD.
      • 80     ITGI MEDICAL LTD.
      • 81     IVASCULAR
      • 82     JOHNSON AND JOHNSON (BIOSENSE WEBSTER)
      • 83     JOTEC GMBH
      • 84     LE MAITRE VASCULAR, INC.
      • 85     LEPU MEDICAL
      • 86     LIFETECH SCIENTIFIC CORPORATION
      • 87     LOMBARD MEDICAL TECHNOLOGIES, PLC.
      • 88     MEDINOL LTD.
      • 89     MEDTRONIC, PLC
      • 90     MERIL LIFE SCIENCES PVT. LTD.
      • 91     MERIT MEDICAL SYSTEMS, INC.
      • 92     MIAMI CARDIOVASCULAR INNOVATIONS CORP.
      • 93     MICELL TECHNOLOGIES, INC.
      • 94     MICROPORT SCIENTIFIC CORPORATION
      • 95     MILLAR INSTRUMENTS, INC.
      • 96     MINVASYS
      • 97     MITRAGEN
      • 98     MIV THERAPEUTICS INC.
      • 99     NANO ENDOLUMINAL S.A.
      • 100     NATEC MEDICAL
      • 101     OCT MEDICAL IMAGING, INC.
      • 102     OPSENS MEDICAL
      • 103     OPTIMED MEDIZINISCHE INSTRUMENTE GMBH
      • 104     OPTIRAY MEDIZINTECHNIK GMBH
      • 105     OPTO CIRCUITS INDIA LIMITED
      • 106     ORBUSNEICH
      • 107     PENUMBRA, INC.
      • 108     PFM MEDICAL AG
      • 109     PHILIPS
      • 110     POLYMEREX MEDICAL CORP.
      • 111     PROCYRION, INC.
      • 112     QT VASCULAR
      • 113     RELISYS MEDICAL DEVICES LIMITED
      • 114     REVA MEDICAL, INC.
      • 115     REX MEDICAL
      • 116     SAHAJANAND MEDICAL TECHNOLOGIES PVT. LTD.
      • 117     SICHUAN JINJIANG ELECTRONIC SCIENCE AND TECHNOLOGY CO., LTD
      • 118     SIEMENS HEALTHCARE
      • 119     ST. GEORGE MEDICAL
      • 120     STENTYS S.A.S.
      • 121     STRAUB MEDICAL
      • 122     STRYKER CORPORATION
      • 123     SURGICAL SPECIALTIES CORPORATION
      • 124     TELEFLEX, INC.
      • 125     TERUMO CORPORATION
      • 126     TRANSCATHETER TECHNOLOGIES GMBH
      • 127     TRANSLUMINA GMBH
      • 128     TRYTON MEDICAL, INC.
      • 129     VACTRONIX SCIENTIFIC INC.
      • 130     VASCULAR CONCEPTS
      • 131     VASCULAR SOLUTIONS INC.
      • 132     VOLCANO CORPORATION (PHILIPS)
      • 133     W.L. GORE& ASSOCIATES
      • 134     XTENT, INC.